LobbyingAssociation for Clinical Oncology lobbying by quarter
Association for Clinical Oncology's latest lobbying report covers Q2 2026, at $550K. The four quarters Q4 2025–Q3 2026 total $1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Association for Clinical Oncology
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $140K | 2 |
| Q1 2023 | $250K | 2 |
| Q2 2023 | $520K | 2 |
| Q3 2023 | $160K | 2 |
| Q4 2023 | $190K | 2 |
| Q1 2024 | $260K | 2 |
| Q2 2024 | $600K | 2 |
| Q3 2024 | $180K | 2 |
| Q4 2024 | $150K | 2 |
| Q1 2025 | $320K | 2 |
| Q2 2025 | $720K | 2 |
| Q3 2025 | $180K | 2 |
| Q4 2025 | $190K | 2 |
| Q1 2026 | $280K | 2 |
| Q2 2026 | $550K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.9M · 30 reports
- Budget and appropriations$1.1M · 18 reports
- Medicare and Medicaid$1M · 15 reports
- Tobacco$730K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAssociation for Clinical Oncology | $3.7M | 15 quarters |
| Tiber Creek Group | $960K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Tiber Creek Group | $70K |
| 07/16for Q2 | In-house | $480K |
| 04/18for Q1 | Tiber Creek Group | $70K |
| 04/15for Q1 | In-house | $210K |
| 01/20for Q4 2025 | In-house | $120K |
| 01/17for Q4 2025 | Tiber Creek Group | $70K |
| 25/10/20for Q3 2025 | Tiber Creek Group | $70K |
| 25/10/17for Q3 2025 | In-house | $110K |
| 25/07/18for Q2 2025 | Tiber Creek Group | $70K |
| 25/07/17for Q2 2025 | In-house | $650K |
| 25/04/17for Q1 2025 | In-house | $250K |
| 25/04/17for Q1 2025 | Tiber Creek Group | $70K |
| 25/01/19for Q4 2024 | Tiber Creek Group | $60K |
| 25/01/17for Q4 2024 | In-house | $90K |
| 24/10/18for Q3 2024 | In-house | $120K |
| 24/10/11for Q3 2024 | Tiber Creek Group | $60K |
| 24/07/22for Q2 2024 | In-house | $540K |
| 24/07/13for Q2 2024 | Tiber Creek Group | $60K |
| 24/05/03for Q1 2024 | In-house | $200K |
| 24/04/22for Q1 2024 | In-house | $150K |